Answered

Discover answers to your most pressing questions at Westonci.ca, the ultimate Q&A platform that connects you with expert solutions. Get immediate and reliable solutions to your questions from a community of experienced professionals on our platform. Explore comprehensive solutions to your questions from a wide range of professionals on our user-friendly platform.

A key challenge to pediatric medication use is that not all drugs have been tested in this population. Which of the following are legislative acts that address this issue by providing more incentive to manufacturers to conduct tests, allowing FDA to take steps to refer drugs for study and requiring manufacturers to conduct tests when it is likely a medication will be used in pediatric patients?
A. The Best Pharmaceuticals for, Children Act (BPCA)
B. The Pediatric Research Equity Act (PREA)
C. The Creative Incentives for Pediatric Testing Act (CIPTA)
D. Both A and B

Sagot :

We hope you found this helpful. Feel free to come back anytime for more accurate answers and updated information. We appreciate your visit. Our platform is always here to offer accurate and reliable answers. Return anytime. Thank you for choosing Westonci.ca as your information source. We look forward to your next visit.